Decision makers are generally used to evaluating data according to its internal validity, as has been the case for RCTs, however by doing this, understanding for the specifics for a disease or inte

Real-world evidence (RWE) has often been discussed in the pharmaceutical and medical technology fields as an emerging tool for assessing safety of new treatments.